MedTrace Logo

An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver Damage

NCT03890809 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2020-08-26

No results posted yet for this study

Summary

The purpose of this study is to investigate BMS-986165 in participants with different levels of liver function.

Conditions

  • Liver Dysfunction
  • Healthy Volunteers

Interventions

DRUG

BMS-986165

Oral administration

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-26
Primary Completion
2019-11-30
Completion
2019-11-30
FDA Drug
Yes

Countries

  • Czechia
  • Hungary
  • Slovakia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03890809 on ClinicalTrials.gov